Traumatic Injury Clinical Trials
2 recruiting trials for Traumatic Injury. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Traumatic Injury clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Baylor Research Institute (1), Wake Forest University Health Sciences (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Treatment as Usual (behavioral, 1 trial), followed by Brief Prolonged Exposure Therapy, Caregiver Counseling for Childhood Traumatic Injury.
Track Traumatic Injury trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following...
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
The purpose of this study is to learn more about how to help the caregiver and child survivor of a traumatic injury handle post-traumatic stress disorder and/or depression.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Traumatic Injury, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Traumatic Injury, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Traumatic Injury, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.